Fosamax Has New Dosages Approved By FDA

Fosamax Has New Dosages Approved By FDA

Monday, January 9th, 2012 | Medicine | admin

The Food and Drug Administration (FDA) has approved two new dosage strengths of Merck & Co., Inc.’s Fosamax (alendronate sodium), once-weekly tablets 70 mg for the treatment of postmenopausal osteoporosis and 35 mg for the prevention of postmenopausal osteoporosis. These new dosages are to further help those fighting against Fosamax Femur Fractures.

Fosamax is currently the only oral medication that is FDA approved for treatment and prevention of postmenopausal osteoporosis in a once-weekly dosing regimen. “For the millions of postmenopausal women who currently have osteoporosis or are at risk for the disease, the FDA’s decision to approve Fosamax in a once-weekly dose marks an important development in the treatment and prevention of osteoporosis,” said Thomas J. Schnitzer, M.D., Ph.D., professor and director, Office of Clinical Research and Training, Northwestern University. Dr. Schnitzer goes on to say as well that “Patients and their health care professionals now have the opportunity to choose between once-daily and once-weekly Fosamax, and the once-weekly regimen may be more convenient for some patients.”

Fosamax continues to be available in once-daily dosages for the treatment (10 mg) and prevention (5 mg) of postmenopausal osteoporosis in addition to the new once-weekly dosages in the 70 mg and 35 mg strengths.

A higher dose of Fosamax is required when treating Paget’s disease which is 40 mg once daily for six months. It may become necessary for your doctor to recommend you start taking Fosamax again after monitoring your progress for six months after stopping the drug Vitamin D and calcium should be taken by all Fosamax users as well since the drug cannot help build more bone with them.

Fosamax Tables should be swallowed with a full glass of water while sitting or standing up straight. Patients are also advised not to lie down until they have waited at least 30 minutes after the dose and after they have eaten something. It is also advised that you shouldn’t lie down until you have waited at least 30 minutes after the dose and after you have eaten something. Esophagus irritation may occur if these precautions are not met.

Fosamax users have better help now to combat the bone loss they are experiencing with the newly FDA approved dosages of Fosamax. If there are any complications with the Fosamax treatment then a doctor should be contacted as soon as possible.

URL References:

http://osteoporosis.emedtv.com/fosamax/fosamax-dosage-p2.html

http://www.drugs.com/dosage/fosamax.html